Neogen Corporation

NASDAQ:NEOG

Medical - Diagnostics & Research

Healthcare
$11.08 +1.79%

+$0.16 today

Market cap
$2.42B
Beta
1.80
P/E (TTM)
-3.3
EPS (TTM)
-$2.80
52W Low $4.56High $11.43

Volume 1.79M

Average 2.53M

NEOG Accounts Payables

Cash effect of the change in amounts owed to suppliers; growing payables preserve cash.

Neogen CorporationNASDAQ: NEOG

Accounts Payables · Q1 FY2027 · quarter ended Aug 2026

Accounts payables turns negative

Q1 FY2027 accounts payables was -$1.2M, compared with $14.17M a year earlier. Trailing-twelve-month accounts payables was $4.43M. Over 3 fiscal years it compounded at +2.0% a year.

Context

  • Accounts payables amounted to 2.3% of revenue in FY2026, up 2.2 pp from a year earlier.
  • Accounts payables increased in 1 of the last 3 fiscal years.
  • FY2026 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly accounts payables holds near -$1.2M or moves back toward the trailing-twelve-month quarterly average of $1.11M.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterAug 2026
-$1.2M+71.4% QoQ
Last fiscal yearMay 2026
$19.8M+5025.4% YoY
LTMAug 2026
$4.43M-85.1% YoY
Accounts Payables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-108.5%——
1 year+5025.4%——
3-year CAGR+2.0%——
5-year CAGR——
10-year CAGR——

Accounts Payables history

USD · from the cash flow

Latest · FY2026
19.8M USD
Year-over-year change
+5025.4%
4-year CAGR
-0.5%

Accounts Payables vs competitors

How NEOG compares with its peers on the latest reported figures

  • NEOG's LTM Aug 2026 accounts payables of $4.43M is the 4th largest of the 7 companies compared; the peer median is $4.51M.
  • Its year-over-year change of -85.1% is the 4th highest of 5, against a peer median of -9.6%.
  • Accounts payables amounts to 0.5% of revenue for NEOG, versus a peer median of 0.3%.
NEOG Competitors Peer median
Accounts Payables for NEOG and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ZTSZoetis Inc.LTM Jun 2026$31M -11.4%—0.3%
IDXXIDEXX Laboratories, Inc.LTM Sep 2026$18.98M +230.8%—0.4%
BCPCBalchem CorporationLTM Sep 2026$9.02M -7.7%—0.8%
NEOGNeogen CorporationLTM Aug 2026$4.43M -85.1%+2.0%0.5%
PAHCPhibro Animal Health CorporationLTM Mar 2026$4.2M -109.0%+20.0%0.3%
MRKMerck & Co., Inc.LTM Jun 2026$0 ——0.0%
ELANElanco Animal Health IncorporatedLTM Sep 2026$0 ——0.0%
Peer median (excluding NEOG) $4.51M-9.6%+20.0%0.3%

Competitors are the stored peer set for NEOG. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2022
May 2022
FY2023
May 2023
FY2024
May 2024
FY2025
May 2025
FY2026
May 2026
Net Income48.31M(22.87M)(9.42M)(1.09B)(7.9M)
Depreciation & Amortization24.13M90.47M121.23M125.67M116.3M
Deferred Income Tax(4.7M)(19.23M)(27.42M)(57.78M)(24.3M)
Stock-Based Compensation7.15M10.18M13.77M17.29M13.4M
Change in Working Capital(4.42M)(24.2M)(72.68M)(5.93M)58.8M
Accounts Receivables(7.8M)(53.88M)(20.1M)11.64M6.8M
Inventory(21.07M)9.96M(55.95M)(16.12M)38.2M
Accounts Payables20.24M18.64M13.75M(402K)19.8M
Other Working Capital4.21M1.09M(10.38M)(1.05M)(6M)
Other Non-Cash Items(2.44M)6.67M9.8M1.07B(73.1M)
Operating Cash Flow68.04M41.03M35.26M58.24M83.2M
Capital Expenditures(24.43M)(65.76M)(111.42M)(104.6M)(51.3M)
Acquisitions (Net)(38.75M)12.55M108K5.08M121.7M
Purchases of Investments(415.89M)(12.52M)000
Sales of Investments381.84M266.77M82M325K0
Other Investing Activities0000100K
Investing Cash Flow(97.23M)201.04M(29.31M)(99.2M)70.5M
Debt Repayment0(100M)(420K)(321K)(100M)
Common Stock Issued7.93M1.2M2.46M2.24M1.6M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities(1.12M)(19.28M)(118K)(3.52M)(1M)
Financing Cash Flow6.81M(118.08M)1.92M(1.6M)(99.4M)
Effect of Forex Changes(8.75M)(5.22M)(502K)942K2.2M
Net Change in Cash(31.13M)118.77M7.37M(41.61M)56.5M
Free Cash Flow43.61M(24.73M)(76.16M)(46.35M)31.9M

Neogen Corporation

NASDAQ:NEOG

Intrinsic Alpha fair value

Locked

Current Price

$11.08

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.